Loading…

Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine

Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we so...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 2013-02, Vol.702 (1-3), p.294-301
Main Authors: Ding, Xuekun, Liang, Jing, Zheng, Xigeng, Bai, Yunjing, Liu, Zhengkui, Li, Yingying, Xing, Xiaoli
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213
cites cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213
container_end_page 301
container_issue 1-3
container_start_page 294
container_title European journal of pharmacology
container_volume 702
creator Ding, Xuekun
Liang, Jing
Zheng, Xigeng
Bai, Yunjing
Liu, Zhengkui
Li, Yingying
Xing, Xiaoli
description Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.
doi_str_mv 10.1016/j.ejphar.2013.01.051
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837297508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001429991300071X</els_id><sourcerecordid>1837297508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</originalsourceid><addsrcrecordid>eNqFkc2O1DAQhC0EYmcH3gAhH7kktO38XpBGq2VBWokLnC2P0yEeJXFwO7DDS_DKeJSFIxwsy1ZVV6s-xl4JyAWI6u0px9MymJBLECoHkUMpnrCdaOo2g1rIp2wHIIpMtm17xa6JTgBQtrJ8zq6kUm0lZbVjvw5jxIAdXwZP6YTzaKLzM_c9vxvXg-Bu5nFATjE4E9eJO-KGyNv0SrYfLg589NZPPvrACWdy0f3cZri5W20SHc8cHxZPa0Aeffq2AQ25-SvvPCFdsiYflsHN-II9681I-PLx3rMv728_33zI7j_dfbw53GdWtWXMsK6OlQEjqkrVpimVaqzsQYqiEqYA1VvbQdnXBVRdAXXTgTLCtn19LHsspVB79mabuwT_bUWKenJkcRzNjH4lLRpVy7Yuofm_VIlLmU3aYs-KTWqDJwrY6yW4yYSzFqAv1PRJb9T0hZoGoRO1ZHv9mLAeJ-z-mv5gSoJ3mwBTJd8dBk3W4Zy6dQFt1J13_074DdibrMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1319622885</pqid></control><display><type>article</type><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><source>ScienceDirect Freedom Collection</source><creator>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</creator><creatorcontrib>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</creatorcontrib><description>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2013.01.051</identifier><identifier>PMID: 23396226</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Analgesics, Opioid - administration &amp; dosage ; Animals ; Behavior, Animal - drug effects ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; GluA1 ; Increasing doses ; Male ; MAPK signaling ; Mitogen-Activated Protein Kinases - metabolism ; Morphine ; Morphine - administration &amp; dosage ; Motor Activity - drug effects ; Phosphorylation ; Rats ; Rats, Sprague-Dawley ; Receptors, AMPA - metabolism ; Striatum</subject><ispartof>European journal of pharmacology, 2013-02, Vol.702 (1-3), p.294-301</ispartof><rights>2013 Elsevier B.V.</rights><rights>Copyright © 2013 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</citedby><cites>FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23396226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ding, Xuekun</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zheng, Xigeng</creatorcontrib><creatorcontrib>Bai, Yunjing</creatorcontrib><creatorcontrib>Liu, Zhengkui</creatorcontrib><creatorcontrib>Li, Yingying</creatorcontrib><creatorcontrib>Xing, Xiaoli</creatorcontrib><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</description><subject>Analgesics, Opioid - administration &amp; dosage</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>GluA1</subject><subject>Increasing doses</subject><subject>Male</subject><subject>MAPK signaling</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Morphine</subject><subject>Morphine - administration &amp; dosage</subject><subject>Motor Activity - drug effects</subject><subject>Phosphorylation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, AMPA - metabolism</subject><subject>Striatum</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkc2O1DAQhC0EYmcH3gAhH7kktO38XpBGq2VBWokLnC2P0yEeJXFwO7DDS_DKeJSFIxwsy1ZVV6s-xl4JyAWI6u0px9MymJBLECoHkUMpnrCdaOo2g1rIp2wHIIpMtm17xa6JTgBQtrJ8zq6kUm0lZbVjvw5jxIAdXwZP6YTzaKLzM_c9vxvXg-Bu5nFATjE4E9eJO-KGyNv0SrYfLg589NZPPvrACWdy0f3cZri5W20SHc8cHxZPa0Aeffq2AQ25-SvvPCFdsiYflsHN-II9681I-PLx3rMv728_33zI7j_dfbw53GdWtWXMsK6OlQEjqkrVpimVaqzsQYqiEqYA1VvbQdnXBVRdAXXTgTLCtn19LHsspVB79mabuwT_bUWKenJkcRzNjH4lLRpVy7Yuofm_VIlLmU3aYs-KTWqDJwrY6yW4yYSzFqAv1PRJb9T0hZoGoRO1ZHv9mLAeJ-z-mv5gSoJ3mwBTJd8dBk3W4Zy6dQFt1J13_074DdibrMw</recordid><startdate>20130228</startdate><enddate>20130228</enddate><creator>Ding, Xuekun</creator><creator>Liang, Jing</creator><creator>Zheng, Xigeng</creator><creator>Bai, Yunjing</creator><creator>Liu, Zhengkui</creator><creator>Li, Yingying</creator><creator>Xing, Xiaoli</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130228</creationdate><title>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</title><author>Ding, Xuekun ; Liang, Jing ; Zheng, Xigeng ; Bai, Yunjing ; Liu, Zhengkui ; Li, Yingying ; Xing, Xiaoli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analgesics, Opioid - administration &amp; dosage</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>GluA1</topic><topic>Increasing doses</topic><topic>Male</topic><topic>MAPK signaling</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Morphine</topic><topic>Morphine - administration &amp; dosage</topic><topic>Motor Activity - drug effects</topic><topic>Phosphorylation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, AMPA - metabolism</topic><topic>Striatum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ding, Xuekun</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zheng, Xigeng</creatorcontrib><creatorcontrib>Bai, Yunjing</creatorcontrib><creatorcontrib>Liu, Zhengkui</creatorcontrib><creatorcontrib>Li, Yingying</creatorcontrib><creatorcontrib>Xing, Xiaoli</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ding, Xuekun</au><au>Liang, Jing</au><au>Zheng, Xigeng</au><au>Bai, Yunjing</au><au>Liu, Zhengkui</au><au>Li, Yingying</au><au>Xing, Xiaoli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2013-02-28</date><risdate>2013</risdate><volume>702</volume><issue>1-3</issue><spage>294</spage><epage>301</epage><pages>294-301</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Escalation of drug consumption is involved in the transition from drug use to addiction. Our previous study demonstrated that neuronal activation in ventral tegmental area (VTA) and substantia nigra (SN) was associated with behavioral sensitization induced by increasing doses of morphine. Here we sought to characterize the molecular mechanism underlying this behavioral sensitization. We compared mitogen-activated protein kinase (MAPK) signaling following pretreatment with either increasing doses or fixed doses of morphine before and after behavioral sensitization. We found phospho-MAPK markedly increased in ventral striatum and decreased in dorsal striatum after either pretreatment group, but no further change after sensitization induced by 10mg/kg morphine challenge. Furthermore, we also evaluated the level of phospho-glutamate receptor 1 at serine 845 (pSer845-GluA1) and 831 (pSer831-GluA1) sites in ventral striatum and dorsal striatum. The results showed a significant increase in pSer845-GluA1/GluA1 ratio in ventral striatum but not dorsal striatum after pretreatment with increasing doses of morphine but not after fixed-dose or saline pretreatment. Importantly, pSer845-GluA1/GluA1 ratio was increased exclusively in dorsal striatum and not ventral striatum following acute morphine challenge specifically paired with increasing-dose pretreatment and not fixed-dose or saline. These findings indicate that behavioral sensitization-induced by chronic pretreatment with increasing doses of morphine might be more closely associated with the dynamic GluA1 activity in the striatum rather than the modulation of MAPK signaling. These findings also indicate that GluA1 phosphorylation may occur independent of MAPK activation.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23396226</pmid><doi>10.1016/j.ejphar.2013.01.051</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2013-02, Vol.702 (1-3), p.294-301
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_1837297508
source ScienceDirect Freedom Collection
subjects Analgesics, Opioid - administration & dosage
Animals
Behavior, Animal - drug effects
Corpus Striatum - drug effects
Corpus Striatum - metabolism
GluA1
Increasing doses
Male
MAPK signaling
Mitogen-Activated Protein Kinases - metabolism
Morphine
Morphine - administration & dosage
Motor Activity - drug effects
Phosphorylation
Rats
Rats, Sprague-Dawley
Receptors, AMPA - metabolism
Striatum
title Altered phosphorylation of GluA1 in the striatum is associated with locomotor sensitization induced by exposure to increasing doses of morphine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A35%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20phosphorylation%20of%20GluA1%20in%20the%20striatum%20is%20associated%20with%20locomotor%20sensitization%20induced%20by%20exposure%20to%20increasing%20doses%20of%20morphine&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Ding,%20Xuekun&rft.date=2013-02-28&rft.volume=702&rft.issue=1-3&rft.spage=294&rft.epage=301&rft.pages=294-301&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2013.01.051&rft_dat=%3Cproquest_cross%3E1837297508%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-e76b6a0a16637a85338c2f021461a403fccd05f7406d4078d03a1c9f7b5fe5213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1319622885&rft_id=info:pmid/23396226&rfr_iscdi=true